CD24P1

Across TCGA pan-cancer cohorts, CD24P1 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated CD24P1 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher CD24P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CD24P1 expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

LUSC, KICH, and STAD are the cancer types where CD24P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	II,III,IV	0.383	0.650	.002	75	view →
KICH	OS	Tertile	All	0.082	0.877	<.001	60	view →
STAD	OS	Tertile	All	0.696	0.515	.009	48	view →
PAAD	OS	Tertile	All	0.330	0.596	.038	18	view →
LAML	DFS	Tertile	All	0.206	0.489	.028	18	view →
KIRC	DFS	Tertile	III,IV	0.327	0.507	.026	12	view →
READ	DFS	Tertile	II,III,IV	0.162	0.707	.031	9	view →
COAD	DFS	Tertile	IV	0.237	0.506	.035	9	view →
KIRP	OS	Tertile	All	0.878	0.955	.045	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

CD24P1–LUSC (OS)

Open the LUSC breakdown →